Minzhi Liu

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Marcel H.A. Muskiet, Lennart Tonneijck, Yao‐Kuang Huang et al. · The Lancet Diabetes & Endocrinology · 2018 · 255 citations

Medicine, Cardiology, Pharmacology +11

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

Daniël H. van Raalte, Petter Bjornstad, Frederik Persson et al. · Diabetes Care · 2019 · 88 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical Trial

D. Roger Illingworth, John R. Crouse, Donald B. Hunninghake et al. · Current Medical Research and Opinion · 2001 · 79 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

John J.P. Kastelein, Jonathan L. Isaacsohn, Leiv Ose et al. · The American Journal of Cardiology · 2000 · 72 citations

Life Sciences, Pharmacology, Pharmacotherapy +13

Multiple Imputation and Posterior Simulation for Multivariate Missing Data in Longitudinal Studies

Minzhi Liu, Jeremy M. G. Taylor, Thomas R. Belin · Biometrics · 2000 · 71 citations · Full text

Public Health, Biostatistics, Bayesian Data Analysis +16